Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07419139

Calibration Study PREDICT - Prehospital Triage for Suspected Acute Coronary Syndrome Without ST-segment Elevation

The PREDICT calibration study is a prospective, non-interventional trial aiming to adapt and calibrate the ACS-Pathfinder algorithm for prehospital triage of patients with suspected non-ST-elevation acute coronary syndrome (NSTE-ACS) in Germany. Approximately 304 patients will be enrolled by six emergency medical service (EMS) stations. All patients will receive standard care and an additional point-of-care troponin test (POCT) performed in the ambulance. Clinical and biomarker data will be collected using a study app, without influencing patient management. Follow-up will be conducted up to 90 days through telephone interviews and hospital record review.

The primary objective is to determine the true prevalence of myocardial infarction and calibrate the ACS-Pathfinder algorithm accordingly. Secondary objectives include assessing feasibility, workflow, acceptance, and data processes within the EMS as preparation for a subsequent cluster-randomized main study.

The study is coordinated by Prof. Holger Thiele (Heart Center Leipzig) with co-investigators from Leipzig and Hamburg. The sponsor is Leipzig Heart Science gGmbH. Study duration is planned from January to November 2026.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Suspected myocardial infarction
  • Symptom onset >30 minutes before arrival of emergency medical services
  • Written informed consent

Exclusion criteria

  • STEMI on initial ECG
  • Unstable angina, hemodynamic instability, life-threatening arrhythmias, cardiac arrest
  • Non-ischemic causes requiring hospitalization
  • Emergency physician dispatch at the request of a primary care physician
  • Age <18 years

Treatment and study plan

Primary outcomes

  1. Hospital-confirmed myocardial infarction

    Time frame: from March 2026 to Jun 2026

    The primary endpoint is hospital-confirmed myocardial infarction in patients referred to the PREDICT calibration study by emergency medical services with suspected acute coronary syndrome (ACS).

Study contacts

Contact information is provided by the study sponsor or research team.

Alexander Jobs PD Dr., PD Dr.

CONTACT

[email protected]

+49 341 865 1428

Holger Thiele PD Dr., Prof. Dr.

CONTACT

[email protected]

+49 341 865 14

Sponsors and collaborators

Lead sponsor

Leipzig Heart Science gGmbH

Other

Collaborators

  • Bundesvereinigung der Arbeitsgemeinschaften der Notärzte Deutschlands e.V.
  • Federal Association of Working Groups of Emergency Physicians in Germany
  • Herzzentrum Leipzig - Universitätsklinik für Kardiologie
  • Institut für Gesundheitsökonomie und Versorgungsforschung Medizinische Hochschule Brandenburg - Institut für Sozialmedizin und Epidemiologie
  • Institute for Health Economics and Health Services Research Brandenburg Medical School - Institute for Social Medicine and Epidemiology
  • Institute for Myocardial Infarction Research Foundation (evaluating institute)
  • Leipzig Heart Center - University Clinic for Cardiology
  • Scientific Institute of the AOK Federal Association
  • Stiftung Institut für Herzinfarktforschung (evaluierendes Institut)
  • The German Heart Foundation
  • Universitätsklinikum Hamburg-Eppendorf
  • Wissenschaftliches Institut der AOK Bundesverband

Registry information

Acronym: PREDICT

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Feb 18, 2026
Registry last updated
Feb 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.